US20040177403A1 - Genes encoding protein participating in cytokinin synthesis - Google Patents

Genes encoding protein participating in cytokinin synthesis Download PDF

Info

Publication number
US20040177403A1
US20040177403A1 US10/471,040 US47104003A US2004177403A1 US 20040177403 A1 US20040177403 A1 US 20040177403A1 US 47104003 A US47104003 A US 47104003A US 2004177403 A1 US2004177403 A1 US 2004177403A1
Authority
US
United States
Prior art keywords
leu
ser
val
lys
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/471,040
Other languages
English (en)
Inventor
Tatsuo Kakimoto
Hitoshi Sakakibara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Paper Industries Co Ltd
Suntory Ltd
Original Assignee
Nippon Paper Industries Co Ltd
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Paper Industries Co Ltd, Suntory Ltd filed Critical Nippon Paper Industries Co Ltd
Assigned to SUNTORY LIMITED, NIPPON PAPER INDUSTRIES CO., LTD. reassignment SUNTORY LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KAKIMOTO, TATSUO, SAKAKIBARA, HITOSHI
Publication of US20040177403A1 publication Critical patent/US20040177403A1/en
Priority to US11/398,550 priority Critical patent/US7807867B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8291—Hormone-influenced development
    • C12N15/8295—Cytokinins

Definitions

  • the present invention relates to a gene encoding a protein involved in cytokinin synthesis, a method of utilizing that gene, and a method for acquiring that gene.
  • Cytokinins are an important type of plant hormone. They have various effects including induction of cell division, formation of new buds, overcoming dormancy of axillary buds, prevention of aging and promotion of enlargement of fruit. Cytokinins have a structure in which a dimethylallyl group (isopentenyl group) bonds to a nitrogen atom at position 6 of adenine or adenosine, or has a structure in which the isopentenyl group is hydroxylated as their basic skeleton.
  • a dimethylallyl group isopentenyl group
  • cytokinin synthesis enzymes Some bacteria that are pathogenic to plants are known to have cytokinin synthesis enzymes and among these, the cytokinin synthases of IPT and TZS of Agrobacterium are known to have activity that transfers the dimethylallyl group of dimethylallyl pyrophosphoric acid (DMAPP) to the nitrogen atom at position 6 of adenosine monophosphate (AMP). This reaction is considered to be the most important step in cytokinin synthesis. However, cytokinin synthesis enzymes possessed by plants and the proteins that encode them have yet to be identified.
  • DMAPP dimethylallyl group of dimethylallyl pyrophosphoric acid
  • AMP adenosine monophosphate
  • an object of the present invention is to provide a gene that encodes an enzyme that catalyzes cytokinin synthesis, a protein encoded thereby, and its application.
  • an object of the present invention is to provide a method for identifying that gene.
  • the inventors of the present invention found a method for obtaining a novel gene that encodes an enzyme that catalyzes cytokinin synthesis from Arabidopsis thaliana , and obtained a novel gene that encodes an enzyme that catalyzes cytokinin synthesis.
  • the present invention provides a gene that encodes a protein involved in cytokinin synthesis. More specifically, the protein is a previously unreported enzyme in plants that catalyzes the reaction in which a side chain is introduced at position N6 of the adenine skeleton of cytokinins.
  • the present invention provides a gene that encodes a protein involved in cytokinin synthesis having the amino acid sequence described in SEQ ID NO. 2, 4, 6, 8, 10, 12 or 14.
  • the present invention provides a gene that encodes a protein involved in cytokinin synthesis having a modified amino acid sequence resulting from the addition and/or deletion of one or a plurality of amino acids and/or substitution by other amino acids in SEQ ID NO. 2, 4, 6, 8, 10, 12 or 14.
  • the present invention provides a gene encoding a protein involved in cytokinin synthesis that hybridizes with a nucleic acid described in SEQ ID NO. 1, 3, 5, 7, 9, 11 or 13, and particularly DNA or a portion thereof, under stringent conditions.
  • the present invention also provides a vector that contains that gene.
  • the present invention provides a host that has been transformed by that vector.
  • This host may be a plant cell or a plant body.
  • the present invention is also able to provide a production method of a protein involved in cytokinin synthesis by culturing and cultivating the aforementioned host.
  • the present invention is able to provide a method for regulating the growth of a plant or plant cells by introducing the aforementioned gene into a plant or plant cells and expressing said gene.
  • various physiological actions in which cytokinins are involved such as promotion of the formation of adventitious buds, overcoming the dormancy of lateral buds, prevention of the aging of flowers and leaves and the ripening of fruit, improving the longevity of flowers, maintaining photosynthesis function, promoting the enlargement of fruit, prevention of dropping and control of flowering, can be regulated by expressing this gene.
  • FIG. 1 is a drawing showing the structure of plasmid pTK015.
  • FIG. 2 is a photograph of a plant body regenerated from Arabidopsis thaliana transformed by pHM4-AtIPT5.
  • the inventors of the present invention surmised that the reaction that catalyzes the introduction of an isopentenyl (dimethylallyl) side chain at the N6 position of the adenine skeleton is the rate-limiting step of cytokinin synthesis.
  • genes that are known to encode isopentenyl group transferases involved in cytokinin synthesis include the idt (gene4) gene encoded by T-DNA and the tzs gene present in the vir region of the Ti-plasmid of Agrobacterium tumefaciens , the Dtz gene present in several species of Pseudomonas, the ipt gene of Rhodococcus faciens , and the etz gene of Erwinia herbicola .
  • amino acid sequences of these gene products were first compared to find the amino acid residues preserved therein.
  • the resulting sequence was determined to be GxTxxGK[ST]xxxxx[VLI]xxxxxxx[VLI] [VLI] xxDxxQx[57,60][VLI][VLI]xGG[ST].
  • x indicates an arbitrary amino acid
  • amino acid residues enclosed in brackets [ ] indicate which one of the amino acid residues contained therein
  • [a,b] indicates the number of arbitrary types of amino acid residues greater than or equal to a but less than or equal to b.
  • the genome sequence of Arabidopsis thaliana was searched using a TAIR Pattern Matching program to find the possible genes or estimated gene regions based on this amino acid sequence pattern.
  • the resulting eight genes consisted of AT4g24650 (number of the estimated gene region as determined by the Genome Project), T20010 — 210 (number of the estimated gene region as determined by the Genome Project), 29375-30301 bp of T16G12 (accession number: AC068809) genome clone, MDB19.12 (number of the estimated gene region as determined by the Genome Project), MVI11.6 (number of the estimated gene region as determined by the Genome Project), T26J14.3 (number of the estimated gene region as determined by the Genome Project), F2J7.12 (number of the estimated gene region as determined by the Genome Project) and AF109376.
  • AF109376 an estimated gene, AF109376, has been cloned as the cDNA and annotated as being tRNA isopentenyl transferase mRNA.
  • T20010 — 210, MDB19.12, AT4g24650, MVI11.6, T26J14.3 and F2J7.12 have not being isolated as full length cDNA but estimated genes, and annotated to be likely tRNA isopentenyl transferases. 29375-30301 bp of T16G12 (accession number: AC0699089) genome clone is not even annotated.
  • the genes or estimated genes of AT4g24650, T20010 — 210, cDNA corresponding to 29375-30301 bp of T16G12 (accession number: AC068809) genome clone, MDB19.12, MVI11.6, T26J14.3 and F2J7.12 are designated AtIPT4, AtIPT3, AtIPT5, AtIPT7, AtIPT8 and AtIPT6.
  • each of their nucleotide sequences are shown with SEQ ID NOs. 1, 3, 5, 7, 9, 11 and 13, and their corresponding amino acid sequences are indicated with SEQ ID NOs. 2, 4, 6, 8, 10, 12 and 14.
  • the calli of Arabidopsis thaliana normally form leaves and buds (to be referred to as shoots) when cytokinins are present in the medium, if cytokinins are not present, it does not form any shoots or even if they are formed, the frequency of formation is extremely low. Therefore, if callus efficiently forms shoots even in the absence of cytokinins when a gene has been introduced and expressed in the callus, the introduced gene can be considered to encode a cytokinin synthase or protein involved in cytokinin reactions.
  • the resulting gene can be confirmed to encode a cytokinin synthase or protein involved in cytokinin reactions.
  • plant cytokinin synthase was found to transfer the DMA group of DMAPP to ATP and ADP.
  • Examples of a gene of the present invention include that coding for the amino acid sequence described in SEQ ID NO. 2, 4, 6, 8, 10, 12 or 14.
  • proteins having an amino acid sequence that has been modified by addition or deletion or a plurality of amino acids, and/or substitution by other amino acids are known to maintain activity similar to the original protein.
  • a modified gene that encodes a cytokinin synthase or protein involved in cytokinin synthesis activity and has an amino acid sequence that has been modified with respect to an amino acid sequence described in SEQ ID NO. 2, 4, 6, 8, 10, 12 or 14 by addition or deletion of one or a plurality of amino acids and/or substitution by other amino acids is also included in the present invention.
  • the degree of this modification is the degree which is possible by means that were commonly known technologies prior to filing of the present patent application, examples of which include site-specific mutagenesis, PCR method and so on.
  • the number of amino acids subject to modification while maintaining the activity of the cytokinin synthase or that relating to cytokinin synthesis is, for example 100 or less, for example 50 or less, preferably 25 or less, and for example 10 or less.
  • the present invention also provides a gene composed of DNA that encodes a cytokinin synthase or protein having activity involved in cytokinin synthesis, and which is capable of hybridizing with a nucleic acid having a nucleotide sequence described in SEQ ID NO. 1, 3, 5, 7, 9, 11 or 13, or portion thereof, under stringent conditions.
  • stringent conditions refer to hybridization conditions consisting of 5 ⁇ SSC and 50° C.
  • suitable hybridization temperature varies according to the particular nucleotide sequence and the length of that nucleotide sequence, hybridization can be carried out by suitable selecting the hybridization temperature.
  • a cDNA library, genomic DNA library and so forth prepared from a plant or microorganism, etc. having cytokinin synthase activity or activity involved in cytokinin synthesis can be used for the source of the gene subjected to the aforementioned hybridization, examples of which include plants such as Arabidopsis thaliana , corn, poplar, petunia, tobacco, rice, tomato and eucalyptus plants.
  • the nucleotide sequence of a gene encoding a cytokinin synthase or protein involved in cytokinin synthesis obtained in this manner has homology of 50% or more, 60% or more, preferably 70% or more or 80% or more, and for example 90% or more, with respect to a nucleotide sequence indicated in SEQ ID NO. 1, 3, 5, 7, 9, 11 or 13.
  • the subject gene encoding a protein having an amino acid sequence indicated in SEQ ID NO. 2, 4, 6, 8, 10, 12 or 14 can be obtained from Arabidopsis thaliana in the form of cDNA or genomic DNA.
  • DNA encoding a protein having a modified amino acid sequence can be synthesized using commonly used site-specific mutagenesis or PCR method by using DNA having the inherent nucleotide sequence as a base.
  • a DNA fragment containing a desired modification can be obtained by obtaining a DNA fragment in which a modification is desired to be introduced by restriction enzyme treatment of the inherent cDNA or genomic DNA, and then performing site-specific mutagenesis or PCR method using this DNA as a template and a primer containing the desired mutation. Subsequently, this DNA fragment into which the mutation has been introduced should then be coupled with a DNA fragment that encodes another portion of the target protein.
  • DNA that encodes protein composed of a shortened amino acid sequence in order to obtain DNA that encodes protein composed of a shortened amino acid sequence, DNA that encodes an amino acid sequence longer than the target amino acid sequence, such as the entire amino acid sequence, should be digested by a desired restriction enzyme and, if the resulting DNA fragment does not encode the entire target amino acid sequence, a DNA fragment composed of the portion of the sequence that is lacking should be synthesized and then coupled to that fragment.
  • cytokinin synthase or a protein having activity involved in cytokinin synthesis can also be obtained by using antibody to a protein having an amino acid sequence described in SEQ ID NO. 2, 4, 6, 8, 10, 12 or 14, and cytokinin synthase or protein having activity involved in cytokinin synthesis of other organisms can be cloned using antibody.
  • the present invention also relates to a recombinant vector, and particularly an expression vector, that contains the aforementioned gene, and to a host transformed by said vector.
  • Procaryotic organisms or eucaryotic organisms can be used as hosts.
  • Examples of prokaryotic organisms include bacteria such as Escherichia coli and other Escherichia species, Bacillus subtilis and other Bacillus species as well as other commonly used host microorganisms.
  • Examples of eucaryotic organisms include lower eucaryotic organisms such as eucaryotic microorganisms in the form of yeasts and molds.
  • yeasts include Saccharomyces cerevisiae and other Saccharomyces species
  • molds include Aspergillus oryzae, Aspergillus niger and other Aspergillus species as well as Penicillium species.
  • plant cells and animal cells may also be used as hosts, examples of which include cells systems of animals cells such as mouse, hamster, monkey or human cells, and more specifically, COS cells, Vero cells, CHO cells, L cells, C127 cells, BALB/c 3T3 cells and Sp-2/0 cells.
  • Examples of plant cells include tobacco and Arabidopsis cultured cells as well as cultured cells of poplar, eucalyptus and acacia species.
  • insect cells such as silkworm ( Bombyx mori ) cells or adult silkworms themselves can be used as hosts.
  • silkworm Bombyx mori
  • yoga Spodoptera frugiprd
  • cabbage looper Trichoplusiani
  • Plasmids, phages, phagemids and viruses can be used as expression vectors.
  • viruses such as Baculovirus (expression in insects) or Vaccinia virus (expression in animal cells)
  • Baculovirus expression in insects
  • Vaccinia virus expression in animal cells
  • Expression vectors of the present invention contain expression control regions such as promoters, terminators, replication origins and so forth depending on the type of host into which they are to be introduced.
  • promoters of bacterial expression vectors include lac promoter
  • yeast promoters include glyceraldehyde 3-phosphate dehydrogenase promoter, PHO5 promoter, adhi promoter and pqk promoter
  • mold promoters include amylase promoter and trpC promoter.
  • examples of insect promoters include Baculovirus polyhedron promoter, and examples of animal cell promoters include Simian Virus 40 early and late promoters, CMV promoter, HSV-TK promoter or SRa promoter.
  • examples of plant promoters include the 35S promoter of cauliflower mosaic virus and nopaline synthase promoter, while examples of inductive promoters include glutathione-S-transferase II gene promoter, hsp80 promoter and ribulose 2-phosphate carboxylase small subunit gene promoter.
  • preferable modes of the expression vector include, in addition to those described above, those containing enhancers, splicing signals, poly A addition signals or selection markers (for example, dihydrofolic acid reductase genes (methotrexate resistant) and neo genes (G418 resistant)). Furthermore, in the case of using an enhancer, SV40 enhancer, for example, is inserted upstream or downstream from the gene.
  • Host transformation by an expression vector can be carried out in accordance with ordinary methods well known among persons with ordinary skill in the art, and these methods are described in, for example, Current Protocols in Molecular Biology, John Wiley & Sons Publishing, 1995. Culturing of the transformant can also be carried out in accordance with ordinary methods. Purification of protein involved in cytokinin synthesis from the culture can be carried out in accordance with ordinary methods for isolating and purifying proteins, examples of which include ultrafiltration and various types of column chromatography such as chromatography using Sepharose.
  • CAA82744.1 the dimethylallyl transferase gene of Erwinia herbicola (Accession No. Z46375-2, Protein ID No. CAA86510.1) and the ⁇ -2-isopentenyl phosphate (IPP) transferase gene of Escherichia coli tRNA (Accession No. U14003-83, Protein ID No. AAA97067.1) using the amino acid sequence comparison software, Clustal V of Macvector 6.5.3, the preserved sequence of GxTxxGK[ST]xxxxx[VLI]xxxxxxx[VLI][VLI]xxDxxQx[57,60][VLI] [VLI]xGG[ST] was found.
  • x indicates an arbitrary amino acid
  • amino acid residues enclosed in brackets [ ] indicate which one of the amino acid residues contained therein
  • [a,b] indicates the number of arbitrary types of amino acid residues greater than or equal to a but less than or equal to b.
  • pBI35T (WO 01/16332) was treated with EcoRI and HindIII to obtain a DNA fragment containing a promoter of cauliflower mosaic virus 35S RNA gene, a multi-cloning site and the terminator of 35S RNA gene. This was then treated with HindIII and EcoRI of pGPTV-KAN (Becker, R., et al., Plant Molecular Biology, 20, 1195-1197, 1992), and among the two fragments formed, the longer fragment was ligated to obtain pTK015 (FIG. 1).
  • this DNA fragment containing a promoter of cauliflower mosaic virus 35S RNA gene, a multi-cloning site and the terminator of 35S RNA gene was then treated with HindIII and EcoRI of pGPTV-Bar (Becker, R., et al., Plant Molecular Biology, 20, 1195-1197, 1992), and among the two fragments formed, the longer fragment was ligated to obtain pTK016.
  • DNA was amplified by incubating at 94° C. for 2 minutes followed by 40 cycles consisting of 15 seconds at 94° C., 30 seconds at 53° C. and 2 minutes and 40 seconds at 68° C. using the cDNA library of Arabidopsis thaliana for the template DNA of the PCR reaction, primer 398 (5′-TCCCCCGGGCGATGATGATGTTAAACCCTAGC-3′) (SEQ ID NO. 15) and primer 399 (5′-TCCCCCGGGTC AATTTACTTCTGCTTCTTGAACTTC) (SEQ ID NO.
  • AtIPT4 was amplified by incubating at 94° C. for 2 minutes followed by 42 cycles consisting of 15 seconds at 94° C., 20 seconds at 53° C. and 1 minute at 68° C. using the genomic DNA of Arabidopsis thaliana for the template of the PCR reaction, primer 421 (AAAATGAAGTGTAATGACAAAATGGTTGTG-3′) (SEQ ID NO. 17) and primer 407 (5′-GTCCAAACTAGTTAAGACTTAAAAATC-3′) (SEQ ID NO. 18) as primers and pfx DNA polymerase (Gibco BRL), followed by purification and cloning to the SmaI site of pTK015.
  • the cloned product in the sense direction downstream from the 35S promoter was designated as pTK015-AtIPT4.
  • DNA was amplified using genomic DNA of Arabidopsis thaliana for the template, primer 703 (5′-CACCAGCAAGTTTATATTGCAAAGCGT-3′) (SEQ ID NO. 19) and primer 705 (5′-GTTGTAACCACGTAAAAGATAAGGGTG-3′) (SEQ ID NO. 20) as primers and Herculase (trade name, Stratagene) as heat-resistant DNA synthase.
  • the PCR reaction was carried out for 1 minute at 92° C. followed by 35 cycles consisting of 30 seconds at 92° C., 30 seconds at 55° C. and 2 minutes and 30 seconds at 70° C.
  • pTK015 After digesting with SmaI and KpnI, the DNA was purified using the QUIAquick PCR Purification Kit (Qiagen).
  • sequence of the multi-cloning site was altered by cloning primer 852 (5′-CTCGAGTTGGCGCGCCACCCGGGATTAATTAAGAC TAGTGGGTAC-3′) (SEQ ID NO. 27) and primer 853 (5′-CCCACTAGTCTTAATTAA TCCCGGGTGGCGCGCCAACTCGAG-3′) (SEQ ID NO. 28).
  • primer 852 and primer 853 are synthetic DNA having mutually complementary sequences
  • this procedure was carried out by incubating the three elements consisting of a fragment obtained by digesting pTK015 with SmaI and KpnI, primer 852 and primer 853 in the presence of ligase under ordinary conditions.
  • the plasmid produced in this manner was designated as pHM4.
  • the only difference between pHM4 and pTK015 is the sequence of the multi- -cloning site.
  • Those unique sites present in the multi-cloning site of pTK 015 consist of XbaI, XhoI, SmaI, PacI, SpeI, KpnI and SalI.
  • pHM4 pHM4
  • the terminals were blunted by incubating half the amount for 30 minutes at 70° C. in the presence of 200 ⁇ M deoxyATP, deoxyTTP, deoxyCTP, deoxyGTP and 1 unit of pfu DNA polymerase (Stratagene). After treating this for 1 hour at 37° C. with 20 units of calf intestine alkaline phosphatase (Takara), the DNA was purified using the QUIAquick PCR Purification Kit (Qiagen). Here, the cloned DNA fragment that was amplified (for 35 cycles consisting of 20 seconds at 94° C., 30 seconds at 55° C.
  • a sequence containing the entire code region of SEQ ID NO. 6 starting 66 bps upstream from the translation starting point ATG described in SEQ ID NO. 5 was amplified by PCR using genomic DNA extracted from a Columbia wild strain (Takara Shuzo) as a template and using primer 856 (5′-CCGCTCGAGA TGAAGCCATGCATGACGGCTC-3′) (SEQ ID NO. 33) and primer 857 (5′-GGACTAGTCACCGGGAAATCGCCGCCA-3′) (SEQ ID NO. 34). These primers contain restriction enzyme sites and were treated with XhoI and SpeI following PCR. This DNA fragment was cloned to pHM4, a vector excessive expression in plants, and designated as pHM4-AtIPT5.
  • pTK015, pTK015-AF109376, pTK015-AtIPT4 and pTK016-AtIPT3 were inserted into the callus of Arabidopsis thaliana using Agrobacterium.
  • the method for inserting genes using Agrobacterium was in accordance with the method of Akama, et al. (Akama, K. et al., 1992 Plant Cell Rep., 12, 7-11).
  • the calli containing the inserted genes were cultured in two types of media consisting of cytokinin-free medium [GM medium (Akama, K.
  • cytokinin-containing medium cytokinin-free medium containing 0.5 ⁇ g/ml of trans-zeatin
  • calli transformed with pTK015-AtIPT4 formed shoots in both the cytokinin-free and cytokinin-containing medium.
  • calli transformed with pTK016-AtIPT3 similarly formed shoots in both the cytokinin-free and cytokinin-containing media.
  • calli of Arabidopsis thaliana respectively inserted with pHM4, pHM4-AtIPT1, pHM4-AtIPT8 and pHMR-AtIPT5 were cultured in cytokinin-free medium containing 0.2 ⁇ g/ml of indole acetate, 501g/ml of kanamycin and 100 ⁇ g/ml of claforan.
  • the procedure was the same as the example in which AtIPT4 was inserted into calli.
  • the calli containing pHM4 did not form shoots
  • the calli containing pHM4-AtIPT1, pHM4-AtIPT8 and pHM4-AtIPT5 formed shoot tissue.
  • AtIPT4 and AtIPT3 were suggested to have the ability to induce shoots and the ability to synthesis cytokinins.
  • AtIPT1 AtIPT5
  • AtIPT3 excessive expression of AtIPT1, AtIPT5 and AtIPT3 is capable of causing a cytokinin response.
  • pHM4-AtIPT5 was transformed in Arabidopsis thaliana using the vacuum infiltration Agrobacterium infection method (O. Araki, Shujunsha Publishing, Cell Engineering Supplement, Plant Cell Engineering Series 4, Experimental Protocols in Model Plants, p. 109-113).
  • the resulting seeds were cultivated in MS agar medium containing 50 ⁇ g/ml of kanamycin followed by selection of transformants.
  • the transformants were cultivated in vermiculite containing one-half the concentration of MS medium, an extremely large number of lateral buds were formed in several of the plants (causing the plants to appear bushy) (FIG. 2). This phenotype was not observed in pHM4 transformants cultivated as a control. As a result, it was determined that when AtIPT5 is expressed in excess, terminal bud dominance diminishes and lateral bud formation is promoted.
  • the code region was amplified by using the pTK015-AtIPT4 produced in Example 2 as a template, using primer 480 (5′-GGAATTCCATATGAAGTGTAATGACAAAATGGTTG ⁇ circumflex over ( ) ⁇ 3′) (SEQ ID NO. 21) and primer 481 (5′-GAAGATCTGTCCAAACTAGTTAAGACTTAAAAA TC-3′) (SEQ ID NO. 22) as primers, and using LA taq (Takara Shuzo). After purifying the amplified region, it was treated with NdeI and BglII followed by again purifying the DNA. This DNA fragment was cloned between the NdeI and BamHI sites of pET16b (Novagen) to produce pET16b-AtIPT4.
  • the coding region was amplified using pTK015-AF109376 as the template for the PCR reaction, using primer 550 (5′-GATCCCCGGCATATGATGATGTTAAACCCTAGC-18-3′) (SEQ ID NO. 23) and primer 551 (5′-ACGGTACCCATA TGTCAATTTACTTCTGCTTCTTGAAC-3′) (SEQ ID NO. 24) as primers, and using Herculase (Stratagene) as heat-resistant DNA polymerase. This was then treated with NdeI and cloned to the NdeI site of pET16b to produce pET16b-AF109376.
  • the coding region was amplified using genomic DNA of Arabidopsis thaliana as the template for the PCR reaction, using primer 741 (5′-TTATACATATGAAGCCATGCATGACGGCTCTAAG-3′) (SEQ ID NO. 25) and primer 742 (5′-CGGGATCCTCACCGGG AAATCGCCGCCA-3′) (SEQ ID NO. 26) as primers, and using LA taq (Takara Shuzo) as heat-resistant enzyme. Following purification, the DNA was treated with NdeI and BamHI and cloned between the NdeI and BamHI sites of pET15b (Novagen) to produce pET15b-AtIPT5.
  • AtIPT1, AtIPT4, AtIPT8 and AtIPT6 form a single subgroup, while AtIPT3, AtIPT5 and AtIPT7 form a different subgroup.
  • Enzyme activity in E. coli was measured from each for a single gene.
  • coli were then centrifuged for 10 minutes at 300000 g followed by recovery of the supernatants. 10 ⁇ l of these supernatants were mixed with Buffer A containing 60 ⁇ M DMAPP, 5 ⁇ M [3H]AMP (722 GBq/mmol) and 10 mM MgCl 2 followed by incubation for 30 minutes at 25° C. Subsequently, 50 mM of Tris-HCl (pH 9) was added to this reaction liquid followed by the addition of calf intestine alkaline phosphatase to a concentration of 2 units/30 ⁇ l and incubating for 30 minutes at 37° C. to carry out a dephosphatization reaction.
  • Buffer A containing 60 ⁇ M DMAPP, 5 ⁇ M [3H]AMP (722 GBq/mmol) and 10 mM MgCl 2 followed by incubation for 30 minutes at 25° C.
  • 50 mM of Tris-HCl (pH 9) was added to this reaction liquid followed by
  • AtIPT4 was cloned in pET32b (Novagen) and an extract was prepared from E. coli in the same manner as Example 3, Part (ii). This was designated as Sample A.
  • 400 ⁇ l of Ni-NTA agarose suspension (containing 110 ⁇ l of Ni-NTA agarose as precipitate, 30 mM NaH 2 PO 4 (pH 8), 15 mM indazole, 0.9 M NaCl, 7.5 mM ⁇ -mercaptoethanol, 0.5 mM PMSF and 30 ⁇ g/ml of leupeptin) were added to 800 ⁇ l of Sample A. This suspension was designated as Sample B.
  • Sample B was then centrifuged to separate into supernatant (Sample C) and precipitate.
  • Washing liquid consisting of 20 mM NaH 2 PO 4 (pH 8), 10 mM indazole, 0.3 M NaCl, 5 mM ⁇ -mercaptoethanol, 0.5 mM PMSF and 10 ⁇ g/ml of leupeptin
  • Sample D 50 ⁇ l of Sample D were then mixed with 50 ⁇ l of 2 ⁇ reaction liquid (25 mM Tris-HCl (pH 7.5), 75 mM KCl, 10 mM MgCl 2 , 10 ⁇ g/ml of leupeptin, 1 mM PMSF and 66 ⁇ M DMAPP) containing one of the nucleotides of ATP, ADP or AMP or adenosine or adenine at 0.25 ⁇ M, which were labeled with 3 H, and allowed to react for 30 minutes at 23° C.
  • 2 ⁇ reaction liquid 25 mM Tris-HCl (pH 7.5), 75 mM KCl, 10 mM MgCl 2 , 10 ⁇ g/ml of leupeptin, 1 mM PMSF and 66 ⁇ M DMAPP
  • AtIPT1 also encoded protein having activity that transfers a dimethylallyl group to ATP and ADP.
  • the aforementioned Sample D was mixed with an equal volume of 2 ⁇ reaction liquid (containing 1 mM ATP and 1 mM DMAPP) and allowed to react for 1 hour at 25° C. After centrifuging, the supernatant was divided into two equal portions, and one of the portions was treated with calf intestine alkaline phosphatase in the same manner as previously described. After diluting each portion with 3 volumes of acetone and holding for 30 minutes at ⁇ 80° C., they were centrifuged for 30 minutes at 17,000 ⁇ g to remove the protein. After drying the supernatant to a solid under reduced pressure, it was dissolved in methanol.
  • 2 ⁇ reaction liquid containing 1 mM ATP and 1 mM DMAPP
  • a portion of the dried supernatant was fractionated with the Chemocobond ODS-W column (Chemco). Elution was carried out using a linear concentration gradient by first eluting for 15 minutes with 20 mM KH 2 PO 4 followed by 30 minutes with an 80% aqueous acetonitrile solution containing K 2 HPO 4 ranging from 20 mM to 4 mM.
  • the sample not treated with calf intestine alkaline phosphatase exhibited two main peaks in Chemocobond ODS-W column chromatography. The retention time of the peak that eluted first coincided with the retention time of ATP.
  • the retention time of the peak (Peak A) that eluted later did not coincide with any of the retention times of ATP, adenosine or isopentenyl adenosine.
  • the sample treated with calf intestine alkaline phosphatase also exhibited two main peaks in Chemocobond ODS-W column chromatography.
  • the retention time of the peak that eluted first coincided with the retention time of adenosine, while the retention time of the peak that eluted later (Peak B) coincided with that of isopentenyl adenosine.
  • Peak A After drying the fractions of Peaks A and B, they were dissolved in ethanol and analyzed by fast atom bombardment mass spectrometry (JMS-SX102 or JEOL Mstation, JOEL Datum Ltd.). As a result, a signal originating in the compound of Peak A was unable to be obtained, because of inhibition of ionization by the triphosphate group. Signals originating in the compound of Peak B were observed at m/z values of 336 and 204, with the former corresponding to isopentenyl adenosine, and the latter corresponding to a decomposition product of isopentenyl adenosine. On the basis of the above, Peak A was thought to be isopentenyl ATP (also referred to as iPTP), which is a compound resulting from the phosphatization of isopentenyl adenosine.
  • iPTP isopentenyl ATP
  • ATP can be efficiently used as a substrate of cytokinin synthesis, these genes are expected to function more effectively in plants than cytokinin synthesis genes originating in bacteria using AMP as substrate.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
US10/471,040 2001-03-12 2002-03-12 Genes encoding protein participating in cytokinin synthesis Abandoned US20040177403A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/398,550 US7807867B2 (en) 2001-03-12 2006-04-06 Gene encoding protein involved in cytokinin synthesis

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-69489 2001-03-12
JP2001069489 2001-03-12
PCT/JP2002/002315 WO2002072818A1 (en) 2001-03-12 2002-03-12 Genes encoding proteins participating in cytokinin synthesis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/398,550 Division US7807867B2 (en) 2001-03-12 2006-04-06 Gene encoding protein involved in cytokinin synthesis

Publications (1)

Publication Number Publication Date
US20040177403A1 true US20040177403A1 (en) 2004-09-09

Family

ID=18927516

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/471,040 Abandoned US20040177403A1 (en) 2001-03-12 2002-03-12 Genes encoding protein participating in cytokinin synthesis
US11/398,550 Expired - Fee Related US7807867B2 (en) 2001-03-12 2006-04-06 Gene encoding protein involved in cytokinin synthesis

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/398,550 Expired - Fee Related US7807867B2 (en) 2001-03-12 2006-04-06 Gene encoding protein involved in cytokinin synthesis

Country Status (10)

Country Link
US (2) US20040177403A1 (de)
EP (1) EP1384776B1 (de)
JP (1) JP4334228B2 (de)
CN (1) CN1496401B (de)
AT (1) ATE441708T1 (de)
AU (1) AU2002237573B2 (de)
CA (1) CA2441791A1 (de)
DE (1) DE60233563D1 (de)
NZ (1) NZ528152A (de)
WO (1) WO2002072818A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050164370A1 (en) * 2003-10-10 2005-07-28 Sumitomo Chemical Company, Limited Transformed cell co-expressing cytokinin receptor and cytokinin biosynthesis enzyme
US20230203520A1 (en) * 2020-05-06 2023-06-29 Salk Institute For Biological Studies Expression of ipt7 from tss promoter increases root mass and carbon sequestration

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060064786A1 (en) * 2004-09-17 2006-03-23 Pioneer Hi-Bred International, Inc. Isopentenyl transferase sequences and methods of use
WO2007090143A2 (en) * 2006-02-01 2007-08-09 Pioneer Hi-Bred International, Inc. Soybean isopentenyl transferase genes and methods of use
EP2067859A4 (de) 2006-09-04 2009-12-02 Riken Verwendung eines aktivierten zytokinin-biosynthetisierenden enzymgens
US20100199380A1 (en) * 2007-06-29 2010-08-05 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
US20160333367A1 (en) * 2013-12-30 2016-11-17 Stora Enso Oyj Method for improving stem volume growth and biomass production in trees
EP4006139A1 (de) * 2020-11-26 2022-06-01 Acies Bio d.o.o. Genetisch manipuliertes bakterium mit der fähigkeit zur herstellung von cytokininen mit isoprenoidseitenketten

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5689042A (en) * 1995-03-29 1997-11-18 Wisconsin Alumni Research Foundation Transgenic plants with altered senescence characteristics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU728915B2 (en) * 1996-05-09 2001-01-18 Nippon Paper Industries Co. Ltd. Vector for introducing a gene into a plant from which a selectable marker gene can be optionally removed
EP1033405A3 (de) * 1999-02-25 2001-08-01 Ceres Incorporated DNS-fragmente mit bestimmter Sequenz und die dadurch kodierte Polypeptide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5689042A (en) * 1995-03-29 1997-11-18 Wisconsin Alumni Research Foundation Transgenic plants with altered senescence characteristics

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050164370A1 (en) * 2003-10-10 2005-07-28 Sumitomo Chemical Company, Limited Transformed cell co-expressing cytokinin receptor and cytokinin biosynthesis enzyme
US20230203520A1 (en) * 2020-05-06 2023-06-29 Salk Institute For Biological Studies Expression of ipt7 from tss promoter increases root mass and carbon sequestration
US12404518B2 (en) * 2020-05-06 2025-09-02 Salk Institute For Biological Studies Expression of IPT7 from TSS promoter increases root mass and carbon sequestration

Also Published As

Publication number Publication date
WO2002072818A1 (en) 2002-09-19
AU2002237573B2 (en) 2008-02-28
EP1384776A4 (de) 2004-12-22
CN1496401A (zh) 2004-05-12
US20060236431A1 (en) 2006-10-19
US7807867B2 (en) 2010-10-05
EP1384776B1 (de) 2009-09-02
NZ528152A (en) 2008-06-30
CA2441791A1 (en) 2002-09-19
DE60233563D1 (de) 2009-10-15
ATE441708T1 (de) 2009-09-15
JP4334228B2 (ja) 2009-09-30
EP1384776A1 (de) 2004-01-28
JPWO2002072818A1 (ja) 2004-07-02
CN1496401B (zh) 2010-05-26

Similar Documents

Publication Publication Date Title
US5767361A (en) Imidazolinone resistant AHAS mutants
US6495354B2 (en) Synthases
Matsuoka et al. Control of plant growth and development by overexpressing MAP3K17, an ABA-inducible MAP3K, in Arabidopsis
CN118931941B (zh) GmC2H2蛋白或其编码基因在植物抗病毒中的应用
US7807867B2 (en) Gene encoding protein involved in cytokinin synthesis
CA2788003A1 (en) Genes encoding proteins able to enhance heat resistance of plants and microorganisms and uses thereof
CA2394759A1 (en) Gibberellin 3.beta.-hydroxylase of rice and uses thereof
US10550409B2 (en) Drimenol synthases III
WO2008029942A1 (fr) Utilisation du gène de l'enzyme de biosynthèse de la cytokinine activée
CN101278049B (zh) 具有给予对三氟羧草醚的抗性的活性的原卟啉原氧化酶及其基因
WO2000047747A2 (en) Maize glutathione-s-transferase enzymes
JP4334584B2 (ja) サイトカイニン合成に関わる蛋白質をコードする遺伝子
CN103052709B (zh) 原伊鲁烯合酶
KR100510430B1 (ko) Ｋａｐａ 신타제 효소 기능을 갖는 식물의 신규폴리펩티드 및 상기 폴리펩티드의 발현을 저해하여 식물생장 억제 및 치사를 유발하는 방법
US6930227B1 (en) Camellia sinensis gene encoding a caffeine synthesis associated n-methyl transferase with 7-methylxanthine n3 methyl transferase, theobromine n1 methyl transferase, and paraxanthine n3 methyl transferase activities and use thereof
WO2001018191A2 (en) Polynucleotides and polypeptides of the phosphoenolpyruvate carboxylase kinase (pepc kinase) family and their variants
US20030167513A1 (en) Selection and use of isopropylmalate synthase (IPMS) mutants desensitized in L-leucine negative feedback control
US20030115638A1 (en) Plants having increased amino acids content and methods for producing the same
AU6731900A (en) Gene coding for protein involved in cytokinin signal transduction
AU6023000A (en) Homeobox gene encoding a protein involved in differentiation
CN121852426A (zh) 一种核酸分子、多肽及其应用
de Oliveira c19) United States c12) Patent Application Publication
JPH09252782A (ja) リン酸トランスポーター遺伝子のプロモーター

Legal Events

Date Code Title Description
AS Assignment

Owner name: NIPPON PAPER INDUSTRIES CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KAKIMOTO, TATSUO;SAKAKIBARA, HITOSHI;REEL/FRAME:015003/0221

Effective date: 20030825

Owner name: SUNTORY LIMITED, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KAKIMOTO, TATSUO;SAKAKIBARA, HITOSHI;REEL/FRAME:015003/0221

Effective date: 20030825

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION